Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation

To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation. Prospective, consecutive study. 12 intensive care units in six towns in Northern Bavaria. A total of 55 apnoea tests were performed on 55 consecutive pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Intensive care medicine 1997-08, Vol.23 (8), p.903-907
1. Verfasser: LANG, C. J. G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 907
container_issue 8
container_start_page 903
container_title Intensive care medicine
container_volume 23
creator LANG, C. J. G
description To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation. Prospective, consecutive study. 12 intensive care units in six towns in Northern Bavaria. A total of 55 apnoea tests were performed on 55 consecutive patients as part of the determination of brain death, 27 without and 28 with CO2 augmentation. Apnoea tests following oxygenation with 100% O2 either after reduction of ventilatory volume (A) or after insufflation of CO2 during normoventilation (B). In each case, an arterial partial CO2 pressure of at least 8 kPa was documented. All apnoea tests were without serious adverse effects (hypoxia, newly induced cardiac arrhythmia, cardiac asystole). An increased dopamine infusion rate was deemed necessary in only one case of group (A) because of marked systolic hypotension (< 8 kPa). Individual variation of systolic and diastolic blood pressure (BP) did not exceed + 62 to -46% and + 49 to -52% respectively, in group (A) and + 35 to -57% and + 40 to -48% respectively, in group (B). Variation of heart rate (HR) remained within the range + 24 to -31% in group (A) and + 37 to -22% in group (B). HR varied less than BP. The possibility of a marked relative rise of fall of BP in group (A) was equal; in group (B) there was a lower change of rising BP. The chances for a rise or fall in HR were equal for the two groups. There was a tendency for less variation of cardiovascular parameters in group (B).
doi_str_mv 10.1007/s001340050430
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79310206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79310206</sourcerecordid><originalsourceid>FETCH-LOGICAL-p263t-1cdec13081244c179aca8f234fe0d4c082be2ee0d25cab7834f773ea129bcad93</originalsourceid><addsrcrecordid>eNpdkM1LAzEQxYMotVaPHoWA4m01k6T7cdTiFxR60ZuwzGaz7ZZtsiZZxP_eVBcPnt4M78fw5hFyDuwGGMtuPWMgJGNzJgU7IFOQgifARX5IpkxInshU8mNy4v02klk6hwmZFAJYDjAl7_edtTXtnfZ-cJqiqelGowvUYdBUbdCstaf14Fqzptgbq5EG7cN-_WzDhlr3o3YIdLHitDV-aJoOQ2vNKTlqsPP6bNQZeXt8eF08J8vV08vibpn0PBUhAVVrBSIG4lIqyApUmDdcyEazWiqW80pzHWc-V1hleTSyTGgEXlQK60LMyPXv3d7ZjyGGK3etV7rr0Gg7-DLbv8tZGsHLf-DWDs7EbCUw4LAvkUXqYqSGaqfrsnftDt1XOZYW_avRR6-waxwa1fo_jGcFh0KIb2NXemA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1012105040</pqid></control><display><type>article</type><title>Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>LANG, C. J. G</creator><creatorcontrib>LANG, C. J. G</creatorcontrib><description>To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation. Prospective, consecutive study. 12 intensive care units in six towns in Northern Bavaria. A total of 55 apnoea tests were performed on 55 consecutive patients as part of the determination of brain death, 27 without and 28 with CO2 augmentation. Apnoea tests following oxygenation with 100% O2 either after reduction of ventilatory volume (A) or after insufflation of CO2 during normoventilation (B). In each case, an arterial partial CO2 pressure of at least 8 kPa was documented. All apnoea tests were without serious adverse effects (hypoxia, newly induced cardiac arrhythmia, cardiac asystole). An increased dopamine infusion rate was deemed necessary in only one case of group (A) because of marked systolic hypotension (&lt; 8 kPa). Individual variation of systolic and diastolic blood pressure (BP) did not exceed + 62 to -46% and + 49 to -52% respectively, in group (A) and + 35 to -57% and + 40 to -48% respectively, in group (B). Variation of heart rate (HR) remained within the range + 24 to -31% in group (A) and + 37 to -22% in group (B). HR varied less than BP. The possibility of a marked relative rise of fall of BP in group (A) was equal; in group (B) there was a lower change of rising BP. The chances for a rise or fall in HR were equal for the two groups. There was a tendency for less variation of cardiovascular parameters in group (B).</description><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s001340050430</identifier><identifier>PMID: 9310811</identifier><identifier>CODEN: ICMED9</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Apnea ; Biological and medical sciences ; Blood Gas Analysis ; Blood pressure ; Blood Pressure - drug effects ; Brain death ; Brain Death - diagnosis ; Carbon dioxide ; Carbon Dioxide - pharmacology ; Cardiac arrhythmia ; Clinical death. Palliative care. Organ gift and preservation ; Dopamine ; Female ; Heart rate ; Heart Rate - drug effects ; Humans ; Hypotension ; Hypoxia ; Insufflation ; Intensive care ; Male ; Medical sciences ; Middle Aged ; Monitoring, Physiologic - methods ; Patients ; Prospective Studies ; Statistics, Nonparametric</subject><ispartof>Intensive care medicine, 1997-08, Vol.23 (8), p.903-907</ispartof><rights>1997 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2792193$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9310811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LANG, C. J. G</creatorcontrib><title>Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation</title><title>Intensive care medicine</title><addtitle>Intensive Care Med</addtitle><description>To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation. Prospective, consecutive study. 12 intensive care units in six towns in Northern Bavaria. A total of 55 apnoea tests were performed on 55 consecutive patients as part of the determination of brain death, 27 without and 28 with CO2 augmentation. Apnoea tests following oxygenation with 100% O2 either after reduction of ventilatory volume (A) or after insufflation of CO2 during normoventilation (B). In each case, an arterial partial CO2 pressure of at least 8 kPa was documented. All apnoea tests were without serious adverse effects (hypoxia, newly induced cardiac arrhythmia, cardiac asystole). An increased dopamine infusion rate was deemed necessary in only one case of group (A) because of marked systolic hypotension (&lt; 8 kPa). Individual variation of systolic and diastolic blood pressure (BP) did not exceed + 62 to -46% and + 49 to -52% respectively, in group (A) and + 35 to -57% and + 40 to -48% respectively, in group (B). Variation of heart rate (HR) remained within the range + 24 to -31% in group (A) and + 37 to -22% in group (B). HR varied less than BP. The possibility of a marked relative rise of fall of BP in group (A) was equal; in group (B) there was a lower change of rising BP. The chances for a rise or fall in HR were equal for the two groups. There was a tendency for less variation of cardiovascular parameters in group (B).</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Apnea</subject><subject>Biological and medical sciences</subject><subject>Blood Gas Analysis</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Brain death</subject><subject>Brain Death - diagnosis</subject><subject>Carbon dioxide</subject><subject>Carbon Dioxide - pharmacology</subject><subject>Cardiac arrhythmia</subject><subject>Clinical death. Palliative care. Organ gift and preservation</subject><subject>Dopamine</subject><subject>Female</subject><subject>Heart rate</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Hypotension</subject><subject>Hypoxia</subject><subject>Insufflation</subject><subject>Intensive care</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monitoring, Physiologic - methods</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Statistics, Nonparametric</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkM1LAzEQxYMotVaPHoWA4m01k6T7cdTiFxR60ZuwzGaz7ZZtsiZZxP_eVBcPnt4M78fw5hFyDuwGGMtuPWMgJGNzJgU7IFOQgifARX5IpkxInshU8mNy4v02klk6hwmZFAJYDjAl7_edtTXtnfZ-cJqiqelGowvUYdBUbdCstaf14Fqzptgbq5EG7cN-_WzDhlr3o3YIdLHitDV-aJoOQ2vNKTlqsPP6bNQZeXt8eF08J8vV08vibpn0PBUhAVVrBSIG4lIqyApUmDdcyEazWiqW80pzHWc-V1hleTSyTGgEXlQK60LMyPXv3d7ZjyGGK3etV7rr0Gg7-DLbv8tZGsHLf-DWDs7EbCUw4LAvkUXqYqSGaqfrsnftDt1XOZYW_avRR6-waxwa1fo_jGcFh0KIb2NXemA</recordid><startdate>19970801</startdate><enddate>19970801</enddate><creator>LANG, C. J. G</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>19970801</creationdate><title>Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation</title><author>LANG, C. J. G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p263t-1cdec13081244c179aca8f234fe0d4c082be2ee0d25cab7834f773ea129bcad93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Apnea</topic><topic>Biological and medical sciences</topic><topic>Blood Gas Analysis</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Brain death</topic><topic>Brain Death - diagnosis</topic><topic>Carbon dioxide</topic><topic>Carbon Dioxide - pharmacology</topic><topic>Cardiac arrhythmia</topic><topic>Clinical death. Palliative care. Organ gift and preservation</topic><topic>Dopamine</topic><topic>Female</topic><topic>Heart rate</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Hypotension</topic><topic>Hypoxia</topic><topic>Insufflation</topic><topic>Intensive care</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monitoring, Physiologic - methods</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Statistics, Nonparametric</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LANG, C. J. G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LANG, C. J. G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation</atitle><jtitle>Intensive care medicine</jtitle><addtitle>Intensive Care Med</addtitle><date>1997-08-01</date><risdate>1997</risdate><volume>23</volume><issue>8</issue><spage>903</spage><epage>907</epage><pages>903-907</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><coden>ICMED9</coden><abstract>To determine changes of blood pressure and heart rate during apnoea testing for brain death without (A) and with (B) artificial CO2 augmentation. Prospective, consecutive study. 12 intensive care units in six towns in Northern Bavaria. A total of 55 apnoea tests were performed on 55 consecutive patients as part of the determination of brain death, 27 without and 28 with CO2 augmentation. Apnoea tests following oxygenation with 100% O2 either after reduction of ventilatory volume (A) or after insufflation of CO2 during normoventilation (B). In each case, an arterial partial CO2 pressure of at least 8 kPa was documented. All apnoea tests were without serious adverse effects (hypoxia, newly induced cardiac arrhythmia, cardiac asystole). An increased dopamine infusion rate was deemed necessary in only one case of group (A) because of marked systolic hypotension (&lt; 8 kPa). Individual variation of systolic and diastolic blood pressure (BP) did not exceed + 62 to -46% and + 49 to -52% respectively, in group (A) and + 35 to -57% and + 40 to -48% respectively, in group (B). Variation of heart rate (HR) remained within the range + 24 to -31% in group (A) and + 37 to -22% in group (B). HR varied less than BP. The possibility of a marked relative rise of fall of BP in group (A) was equal; in group (B) there was a lower change of rising BP. The chances for a rise or fall in HR were equal for the two groups. There was a tendency for less variation of cardiovascular parameters in group (B).</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>9310811</pmid><doi>10.1007/s001340050430</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0342-4642
ispartof Intensive care medicine, 1997-08, Vol.23 (8), p.903-907
issn 0342-4642
1432-1238
language eng
recordid cdi_proquest_miscellaneous_79310206
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Apnea
Biological and medical sciences
Blood Gas Analysis
Blood pressure
Blood Pressure - drug effects
Brain death
Brain Death - diagnosis
Carbon dioxide
Carbon Dioxide - pharmacology
Cardiac arrhythmia
Clinical death. Palliative care. Organ gift and preservation
Dopamine
Female
Heart rate
Heart Rate - drug effects
Humans
Hypotension
Hypoxia
Insufflation
Intensive care
Male
Medical sciences
Middle Aged
Monitoring, Physiologic - methods
Patients
Prospective Studies
Statistics, Nonparametric
title Blood pressure and heart rate changes during apnoea testing with or without CO2 insufflation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A18%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Blood%20pressure%20and%20heart%20rate%20changes%20during%20apnoea%20testing%20with%20or%20without%20CO2%20insufflation&rft.jtitle=Intensive%20care%20medicine&rft.au=LANG,%20C.%20J.%20G&rft.date=1997-08-01&rft.volume=23&rft.issue=8&rft.spage=903&rft.epage=907&rft.pages=903-907&rft.issn=0342-4642&rft.eissn=1432-1238&rft.coden=ICMED9&rft_id=info:doi/10.1007/s001340050430&rft_dat=%3Cproquest_pubme%3E79310206%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1012105040&rft_id=info:pmid/9310811&rfr_iscdi=true